Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 395 | Longs Won 172/395 43% | Profit Factor 1.3 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $7,508.35 |
| Average Win $3,638.39 | Best Trade (Sep 06) $70,083.01 | Sharpe Ratio -51.09 |
| Average Loss -$2,151.11 | Worst Trade (Oct 14) -$47,190.86 | Z-Score -5.91 (100%) |
| Commissions $0 | Avg. Trade Length 1m 3w 4d | Expectancy $375.94 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 0.05% | 0.52% | 1.96% | 5.02% | 10.41% | 18.87% | 31.22% | 48.27% | 70.9% |
| Consecutive Losing Trades | 116 | 104 | 92 | 81 | 69 | 58 | 46 | 35 | 23 | 12 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
BIIB Biogen Inc. | 458.9 | $95,657.16 | $108,666.9 | - | $13,009.74 | 13.6% | +1.705% |
INCY Incyte Corporation | 793.18 | $95,657.16 | $90,009.74 | - | -$5,647.42 | -5.9% | +1.712% |
WVE Wave Life Sciences Ltd. | 15,942.86 | $95,657.16 | $49,821.44 | - | -$45,835.72 | -47.92% | +1.133% |